Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility Study-Reference-Cited by-同舟云学术

Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility Study

Published:2008-01 Issue:1 Volume:70 Page:2-13
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Lee Nancy Y.,Mechalakos James G.,Nehmeh Sadek,Lin Zhixiong,Squire Olivia D.,Cai Shangde,Chan Kelvin,Zanzonico Pasquale B.,Greco Carlo,Ling Clifton C.,Humm John L.,Schöder Heiko

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference73 articles.

1. Head and neck cancer: The importance of oxygen;Terris;Laryngoscope,2000

2. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck;Brizel;Int J Radiat Oncol Biol Phys,1997

3. Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix;Hockel;Gynecol Oncol,1993

4. Hypoxia in head and neck cancer;Isa;Br J Radiol,2006

5. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer;Kaanders;Cancer Res,2002

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of¹⁸F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance;Journal of Nuclear Medicine;2024-09-12

2. Advancements and future directions in positron emission tomography-guided radiotherapy: a narrative review;Chinese Clinical Oncology;2024-04

3. Establishment and Application of Novel Hypoxia-driven Dual-reporter Model to Investigate Hypoxic Impact on Radiation Sensitivity in Human Nasopharyngeal Carcinoma Xenografts;Journal of Cancer;2024

4. Is there a role for [18F]FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature.;2023-10-12

5. Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO;Nuclear Medicine and Biology;2023-09